Sign in
4

Changes in Ownership

SpyGlass Pharma, Inc. Filed Acc 0001193125-26-046676

Director bought 937,500 shares at $16.00 ($15,000,000)

  • Director acquired 6,454,801 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Behbahani Ali Director 2026-02-09 Conversion +1,619,240 1,619,240 I: show line 1 in the form
Behbahani Ali Director 2026-02-09 Conversion +1,370,168 2,989,408 I: show line 2 in the form
Behbahani Ali Director 2026-02-09 Conversion +1,370,168 4,359,576 I: show line 3 in the form
Behbahani Ali Director 2026-02-09 Conversion +737,962 5,097,538 I: show line 4 in the form
Behbahani Ali Director 2026-02-09 Purchase +937,500 $16.00 $15,000,000 6,035,038 I: show line 5 in the form
Behbahani Ali Director 2026-02-09 Conversion +954,990 954,990 I: show line 6 in the form
Behbahani Ali Director 2026-02-09 Conversion +402,273 1,357,263 I: show line 7 in the form
Open-market purchases · 937,500 sh · avg $16.00 · $15,000,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Behbahani Ali Director 2026-02-09 Conversion · Series B Preferred Stock −1,619,240 0 I: show line 8 in the form
Behbahani Ali Director 2026-02-09 Conversion · Series C-1 Preferred Stock −1,370,168 0 I: show line 9 in the form
Behbahani Ali Director 2026-02-09 Conversion · Series C-2 Preferred Stock −1,370,168 0 I: show line 10 in the form
Behbahani Ali Director 2026-02-09 Conversion · Series D Preferred Stock −737,962 0 I: show line 11 in the form
Behbahani Ali Director 2026-02-09 Conversion · Series A Preferred Stock −954,990 0 I: show line 12 in the form
Behbahani Ali Director 2026-02-09 Conversion · Series B Preferred Stock −402,273 0 I: show line 13 in the form
Loading xslF345X05/ownership.xml…